Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic

[1]  T. West,et al.  Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.

[2]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[3]  Mohammad Madjid,et al.  Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.

[4]  Matthew J. Daniels,et al.  Considerations for cardiac catheterization laboratory procedures during the COVID‐19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[5]  Ezekiel J Emanuel,et al.  Fair Allocation of Scarce Medical Resources in the Time of Covid-19. , 2020, The New England journal of medicine.

[6]  Allan Schwartz,et al.  COVID-19 and Cardiovascular Disease , 2020, Circulation.

[7]  Giuseppe Biondi-Zoccai,et al.  Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[8]  C. Siu,et al.  Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China , 2020, Circulation. Cardiovascular quality and outcomes.

[9]  F. Welt,et al.  Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic , 2020, Journal of the American College of Cardiology.

[10]  Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020 , 2020, Journal of Korean medical science.

[11]  N. Hanna,et al.  TRANSSEPTAL VSD CLOSURE IN A PATIENT WITH MECHANICAL AORTIC AND TRICUSPID VALVES , 2020 .

[12]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[13]  Salvatore Rubino,et al.  Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. , 2020, Journal of infection in developing countries.

[14]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[15]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[16]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[17]  M. Mack,et al.  Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel. , 2019, Journal of the American College of Cardiology.

[18]  J. Leipsic,et al.  The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study. , 2019, JACC. Cardiovascular interventions.

[19]  D. Wood,et al.  Risk stratification and clinical pathways to optimize length of stay after transcatheter aortic valve replacement. , 2014, The Canadian journal of cardiology.

[20]  E. Emanuel,et al.  Principles for allocation of scarce medical interventions , 2009, The Lancet.

[21]  E. Ely,et al.  The immunopathogenesis of sepsis in elderly patients. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  N. Kissoon,et al.  Care of the Critically Ill and Injured During Pandemics and Disasters: CHEST Consensus Statement , 2017 .